Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Xenon Pharmaceuticals Inc. (XENE)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 75,280,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Xenon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics for patients with neurological disorders. Co.'s product pipeline of neurology-focused therapies focus on epilepsy. Co.'s product candidates include: XEN1101, a Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders, such as major depressive disorder; and XEN496, a Kv7 potassium channel opener for the treatment of KCNQ2 developmental and epileptic encephalopathy. In addition, Co. has a license and collaboration agreement with Neurocrine Biosciences Inc. to develop NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of epilepsy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 22,229 48,805 236,705 576,095
Total Sell Value $1,027,488 $2,098,369 $9,481,770 $22,449,223
Total People Sold 3 4 7 10
Total Sell Transactions 3 6 11 22
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 231
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kenney Christopher John Chief Medical Officer   •       –      –    2023-03-24 4 S $35.01 $24,507 D/D (700) 0     -
   Pimstone Simon N. Director   –       •      –    2023-03-07 4 S $36.94 $711,199 D/D (19,232) 55,006     -
   Pimstone Simon N. Director   –       •      –    2023-03-07 4 D $37.13 $140,277 D/D (3,778) 63,248     -
   Pimstone Simon N. Director   –       •      –    2023-03-07 4 OE $2.59 $190,225 D/D 72,016 64,866     -
   Azab Mohammad Director   –       •      –    2022-12-12 4 OE $2.68 $8,270 D/D 3,086 69,905     -
   Patou Gary Director   –       •      –    2022-11-25 4 S $34.79 $67,390 D/D (1,937) 23,573     -
   Patou Gary Director   –       •      –    2022-11-25 4 D $34.37 $4,124 D/D (120) 25,510     -
   Patou Gary Director   –       •      –    2022-11-25 4 OE $2.68 $5,513 D/D 2,057 25,630     -
   Patou Gary Director   –       •      –    2022-11-23 4 S $34.33 $70,610 D/D (2,057) 23,573     -
   Aulin Sherry Chief Financial Officer   •       –      –    2022-09-02 4 S $39.57 $607,597 D/D (15,355) 0     -
   Aulin Sherry Chief Financial Officer   •       –      –    2022-09-02 4 D $39.53 $130,172 D/D (3,293) 15,355     -
   Aulin Sherry Chief Financial Officer   •       –      –    2022-09-02 4 OE $3.10 $130,061 D/D 18,648 18,648     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-09-01 4 S $38.03 $1,675,476 D/D (43,879) 16,796     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-09-01 4 D $38.81 $237,556 D/D (6,121) 60,675     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-09-01 4 OE $4.75 $237,500 D/D 50,000 66,796     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-08-31 4 S $38.57 $823,547 D/D (21,352) 16,796     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-08-31 4 D $37.86 $59,516 D/D (1,572) 38,148     -
   Robin Sherrington EVP, Strategy & Innovation   •       –      –    2022-08-31 4 OE $2.67 $70,443 D/D 22,488 39,720     -
   Pimstone Simon N. Director   –       •      –    2022-08-16 4 S $38.29 $2,004,901 D/D (52,058) 6,000     -
   Pimstone Simon N. Director   –       •      –    2022-08-15 4 S $37.76 $1,281,650 D/D (33,942) 58,058     -
   Pimstone Simon N. Director   –       •      –    2022-08-12 4 S $37.91 $3,488,598 D/D (91,135) 92,000     -
   Empfield James R. EVP, Drug Discovery   •       –      –    2022-08-12 4 S $38.08 $2,211,978 D/D (57,743) 10,000     -
   Empfield James R. EVP, Drug Discovery   •       –      –    2022-08-12 4 D $38.02 $275,911 D/D (7,257) 67,743     -
   Empfield James R. EVP, Drug Discovery   •       –      –    2022-08-12 4 OE $3.10 $275,750 D/D 65,000 75,000     -
   Pimstone Simon N. Director   –       •      –    2022-03-08 4 S $3.80 $375,636 D/D (14,551) 183,135     -
  231 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us